# China NMPA Drug Inspection - Peking University Medicine Co., Ltd. - Hydroxyethyl starch 130/0.4 sodium chloride injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/peking-university-medicine-co-ltd/fc193e04-f66b-49f3-a1a1-894070eac553/
Source feed: China

> China NMPA drug inspection for Peking University Medicine Co., Ltd. published October 14, 2019. Drug: Hydroxyethyl starch 130/0.4 sodium chloride injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 7, 2019) Announcement No. 16, 2019
- Company Name: Peking University Medicine Co., Ltd.
- Publication Date: 2019-10-14
- Drug Name: Hydroxyethyl starch 130/0.4 sodium chloride injection
- Inspection Finding: [Inspection] Visible foreign matter, does not meet regulations.
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/peking-university-medicine-co-ltd/e44f3acd-c98c-4584-9d1f-e6f605d0c061/